Aurora kinase inhibitor restrains STAT5-activated leukemic cell proliferation by inducing mitochondrial impairment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora kinase inhibitor restrains STAT5-activated leukemic cell proliferation by inducing mitochondrial impairment
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-02
DOI
10.1002/jcp.29680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells
- (2020) Srikanth Elesela et al. PLoS Pathogens
- A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs
- (2019) Svetlana B. Panina et al. Cell Death & Disease
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- Synthesis and biological evaluation of aurora kinases inhibitors based on N -trisubstituted pyrimidine scaffold
- (2018) Liang Long et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Aurora kinase A localises to mitochondria to control organelle dynamics and energy production
- (2018) Giulia Bertolin et al. eLife
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA
- (2016) Tong-You Wade Wei et al. CANCER RESEARCH
- Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
- (2016) Min Yan et al. MEDICINAL RESEARCH REVIEWS
- Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation
- (2016) Le-Xun Wang et al. Scientific Reports
- Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death
- (2015) E. A. Lee et al. CANCER RESEARCH
- Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis
- (2015) Jiao Zhang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- STAT5gene polymorphisms are associated with the response of acute myeloid leukemia patients to Ara-C-based chemotherapy
- (2015) Peipei Xu et al. LEUKEMIA & LYMPHOMA
- Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
- (2014) Elias Jabbour et al. AMERICAN JOURNAL OF HEMATOLOGY
- Unlocking the potential of retinoic acid in anticancer therapy
- (2014) T Schenk et al. BRITISH JOURNAL OF CANCER
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Inhibition of mTOR Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism
- (2013) L.-L. Liu et al. MOLECULAR CANCER RESEARCH
- Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in mice
- (2012) C. Walz et al. BLOOD
- Critical requirement for Stat5 in a mouse model of polycythemia vera
- (2011) D. Yan et al. BLOOD
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
- (2011) B. Lowenberg et al. BLOOD
- High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
- (2011) W. Warsch et al. BLOOD
- The potential role of Aurora kinase inhibitors in haematological malignancies
- (2011) Sherif S. Farag BRITISH JOURNAL OF HAEMATOLOGY
- Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatment
- (2011) Meejeon Roh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia
- (2010) Antonio R. Lucena-Araujo et al. LEUKEMIA RESEARCH
- Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
- (2009) J. Zhou et al. BLOOD
- Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
- (2008) A. Sallmyr et al. BLOOD
- Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression
- (2008) Liang-Yi Hung et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More